About Parexel
One of the largest clinical research organizations, Parexel supports the development of innovative new medicines to improve the health of patients. We provide services to help life sciences and biopharmaceutical customers everywhere transform scientific discoveries into new treatments. From decentralized clinical trials to regulatory consulting services to leveraging real world insights, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.
For 2022 Rare Disease Day, we observed rare disease throughout February, including:
- Jointly issued a press release with n-Lorem Foundation on our partnership to support the development of new investigational therapies for nano-rare patients.
- Hosted a podcast featuring patient advocate and mother/caregiver, Stacy Hurt, and rare disease experts – Sarah Glass (Chief Development Officer, n-Lorem) and Lucas Kempf (Vice President, Regulatory Affairs, Parexel).
- Sponsoring Uplifting Athlete’s 2022 Young Investigator’s Draft
- Posted a video from Beijing Illness Challenge Foundation, a partner of Parexel for rare disease research.
- Posted with Health Advances, a Parexel company, on strategies that drug developers can use to overcome challenges in commercializing treatments for rare diseases.
- Published an observance day post featuring employees and our patient advocate community who have a rare disease or are a caregiver of a loved one with a rare disease.
We look forward to continuing to bring awareness to rare diseases and the importance of clinical research for this community.